Contour Therapeutics is a Palo Alto, California-based company founded in 2020 by Matthew Gibbs .
A joint venture between BridgeBio Pharma and Maze Therapeutics, focused on transforming and advancing breakthrough precision medicine approaches designed to treat cardiovascular disease